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The mechanism of glucagon-induced natriuresis in dogs
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Departments of Physiology and Medicine, McGill University and the McGill University Clinic, Renal and Electrolyte
Division, Royal Victoria Hospital, Montreal, Canada
The mechanism of ghicagon-induced natriuresis in dogs.
Although it is well established that glucagon may exert a
natriuretic effect when administered to dogs, it is not clear
whether this is mediated only by increments in filtered sodium
or by a direct tubular effect. To study this problem we gave
glucagon at 5 tg/min either i.v. or into the renal artery of hydro-
penic, anesthetized dogs. These infusions were followed by a
prompt, modest diuresis. GFR increased by 30% (P<0.0l)
while PAH clearance increased by only 18% (P< 0.05). Sodium
excretion increased by 65 jjEqfmin/kidney (P< 0.01). This
increment in urinary excretion represented from 0.3 to 29% of the
increment in filtered sodium load, with a mean of 6.14%. When
sodium excretion was returned to pre-glucagon levels by reducing
filtered load with an aortic clamp in nine dogs, GFR was found
to be at or above control levels in eight of nine animals. When
this maneuver was reversed so that the left renal artery was
clamped in five dogs prior to the infusion of glucagon, incre-
ments in GFR and UNaV were observed only from the unclamped
kidney. Recollection micropuncture was carried out in 24 end-
proximal tubules of five dogs. Infusion of glucagon caused no
change in TF/P inulin despite an increment in GFR of 24%.
Prior vasodilatation of one kidney with acetylcholine did not
prevent the usual increment of GFR or sodium excretion follow-
ing glucagon.
When glucagon was administered to four chronic caval dogs
with ascites, incremental increases in GFR from 34.7 to 87%
were observed. This increase in filtered load was associated with
increments in sodium excretion ranging from 25 to 312 jiEq/min.
We conclude that 1) the data support the thesis that glucagon
natriuresis is determined largely by increments in the filtered
sodium load. The small percentage of the increment in filtered
sodium appearing in the urine following glucagon makes it
unnecessary to postulate a direct tubular action. Such an effect
however, cannot be definitely ruled out because of the modest
nature of the natriuresis and the limitations in analytical and
micropuncture methodology; 2) glomerulotubular balance is
preserved in the proximal tubule when GFR is increased; 3) the
ability of glucagon to elevate GFR is not abolished by prior
renal vasodilatation; and 4) glucagon may prove useful as an
aid to diuresis in certain clinical situations.
Mécanisme de Ia natriurése induite par le glucagon chez le
chien. Quoiqu'il soit bien établi que le glucagon puisse exercer
un effet natriurétique chez le chien il n'est pas clairement deter.
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mine si ceci est Ia consequence d'une augmentation de Ia charge
de sodium filtré ou d'un effet tubulaire direct. Afin d'étudier ce
problCme nous avons administré du glucagon a 5 Jig/mm, soit
par voie intta veineuse, soit dans l'artère rénale, a des chiens
hydropéniques et anesthésiés. Ces perfusions ont rapidement
entrainé une diurése modérée. Le debit de filtration glomerulaire
(DFG) a augmenté de 30% (P< 0.001) cependant que Ia clearance
du PAH n'augmentait que de 18% (P<0.05). L'excrétion du
sodium a augmenté de 65 jiEq/min/rein (P< 0.01). Cette aug-
mentation de l'excrétion urinaire représente 0.3 a 29 % de
l'augmentation du sodium filtré (moyenne 6.14%). Quand
l'excrétion de sodium a été ramenée aux valeurs observées avant
l'administration de glucagon par reduction de Ia charge filtrée
au moyen d'un clamp aortique chez 9 chiens le DFG s'est trouvé
égal ou supérieur aux valeurs contrôles chez 8 des 9 chiens.
Reciproquement, quand le clamp a eté appligué a l'artCre rénale
gauche chez 5 chiens avant infusion de glucagon, une augmenta-
tion du DFG et du UNaV n'a été observeé que dans le rein
dépourvu de clamp. Des recollections en microponction ont été
faites dans 24 fins de tubules proximaux chez 5 chiens. La
perfusion de glucagon n'a pas modifié Ic TF/P de l'inuline malgré
l'augmentation de 24% du DFG. La vasodilatation préalable
d'un rein par l'acetylcholine n'a pas empêchC l'augmentation du
DFG et de l'excrétion du sodium aprés glucagon. Quand le
glucagon a été adminstré 4 chiens ayant une constriction cave
avec ascite des augmentations du DFG de 34.7 a 87% ont été
observées. Cette augmentation de Ia charge filtrée était associée
a des augmentations de l'excrétion du sodium allant de 25 a
312 jjEq/min. Nous concluons que: I) les données démontrent
que la natriurèse observée apres glucagon est largement due aux
augmentations du DFG. Puisque Ic pourcentage de l'augmenta-
tion du sodium filtré qui apparait dans l'urine suivant l'ad-
ministration du glucagon reste minime, ii est inutile de postuler
une action tubulaire directe. Une telle action n'est pourtant pas
définitivement exclue, Ia natriurCse étant modérée et les techni-
ques analytiques et de microponction étant limitées. 2) l'équilibre
glomérulo-tubulaire est conserve dans le tube proximal quand Ic
DFG est augmenté. 3) Ia capacité du glucagon d'élever Ic DFG
n'est pas abolie par une vasodilatation préalable et 4) le glucagon
peut avoir un intérCt dans certaines situations cliniques pour
augmenter la diurése.
Glucagon is a small polypeptide whose major physiolo-
gical role appears to be participation in the regulation of
blood sugar levels by its action on hepatic gluconeogenesis
and glycogenolysis [I].
Glucagon-induced natriuresis in dogs
In 1957 Staub et a! [2] reported that the intravenous
administration of glucagon to dogs caused a modest
natriuresis independent of its hyperglycemic effect. These
investigators attributed the increment in sodium excretion
to a direct inhibitory effect of the polypeptide on renal
tubular transport processes. Subsequent investigators have
confirmed the natriuretic effects of glucagon when ad-
ministered to man [3], the dog [4] and the rat [5], but have
disagreed as to the mechanisms involved. Both increments
in filtered sodium load [3] and depressed tubular transport
of sodium [2, 6] have been suggested as the factors mediat-
ing this diuretic effect. Because previously published reports
have not adequately quantified these two variables, the
present study was undertaken to more precisely localize
the effect of glucagon within the nephron, using both
clearance and micropuncture techniques.
Methods
Acute experiments were performed on mongrel dogs of
either sex weighing between 12 and 17 kg and deprived
of food and water for 15 to 18 hr prior to the experiment.
The animals were studied under sodium pentobarbital
(Nembutal) anaesthesia, and they received 10 mg of desoxy-
corticosterone acetate (DOCA)' and five units of pitressin
tannate in oil by intramuscular injection 3 to 4 hr prior
to the start of each experiment. All animals were intubated
with a cuffed endotracheal tube and ventilated when
necessary with a Harvard respirator. Ureters were cannu-
lated with PE 205 tubing through flank incisions and urine
was collected separately from each kidney. Arterial blood
samples were collected at the mid-point of each clearance
period from a PE 240 tubing in one femoral artery. The
other femoral artery was used to monitor blood pressure
with a mercury manometer. Inulin and PAH were ad-
ministered in water at 0.5 mI/mm by constant infusion
into a brachial or jugular vein. Priming and infusion doses
were calculated to keep plasma inulin concentration at
50 to 80 mg/l00 ml and plasma PAH at I to 2 mg/100 ml.
At least three or four clearance periods of 10 to 20 mm
duration were obtained in each phase of the experiment.
The experiments were started 45 to 60 mm after the start
of the constant infusions, and at least 20 mm were allowed
for re-equilibration after performing an experimental
maneuver.
A purified glucagon solution2 was used in these experi-
ments and it was administered in saline at 5 ug/min
(0.5 ml/min) by constant infusion into either a peripheral
vein or into the left renal artery through a % 23 gauge
needle inserted in the direction of renal blood flow. The
crystalline glucagon was dissolved in one ml of the supplied
diluent (1.6% glycerine and 0.2% phenol in saline) and
'Percorten, Ciba Co., Dorval, Quebec.
2 Crystalline glucagon hydrochloride, Eli Lilly and Co., Toronto,
Ontario.
then re-diluted in 0.1 liter of physiological saline solution
to yield a final concentration of 10 ug/ml. Appropriate
studies showed that the diluent alone, similarly prepared
and infused, had no effect on renal function in 4 dogs.
Body temperature was monitored with a rectal thermo-
meter and the animal was kept warm with a heating pad.
Experiments were performed according to several
protocols: a) in a total of 26 dogs clearance periods were
first collected during control hydropenia. An infusion of
glucagon was then administered through either a peripheral
vein (15 dogs) or into the left renal artery (11 dogs); after
a 15 to 20 mm equilibration period during which time urine
flow usually stabilized, repeat urine collections were then
obtained sequentially. b) in 9 dogs, after adequate clearance
periods had been collected during glucagon infusion into
a peripheral vein, a Blalock clamp, previously positioned
about the aorta between the renal arteries, was sequentially
tightened to return urinary sodium excretion from the
left kidney as closely as possible to control levels. This
procedure was carried out while sodium excretion from the
clamped kidney was monitored continuously during various
clamp settings. Because of the relatively small glucagon-
induced changes in sodium excretion, it was arbitrarily
decided to accept only those experiments where sodium
excretion could be returned to within 10 to 15 jsEq/min
of control levels. When stable clamp settings were obtained,
another three to four clearance periods were collected.
c) in five dogs the clamp was tightened about the aorta
prior to the infusion of the glucagon. Clearance periods
were collected during a control phase, during the clamp
phase with glucagon, and finally with the clamp off during
continuing glucagon infusion. d) in five dogs the left kidney
was prepared for recollection micropuncture by con-
ventional techniques. A small area of capsule was stripped
away and the exposed surface of the kidney was kept warm
with mineral oil at 37° C. End-proximal tubules were
identified by lissamine green and those to be punctured were
identified by marking them with 1 % nigrosine. Puncture
pipettes (O.D.=7 to 12 t) were placed into the proximal
tubules at a shallow angle and kept carefully centered
within the lumen. Fluid was allowed to enter the pipette
either spontaneously, or more often it was collected by
minimal suction on the aspirating syringe sufficient to
keep a large bolus of mineral oil (3 to 5 times the luminal
diameter) stationary just downstream from the tip of the
collecting pipette. Glucagon was infused into the left
renal artery at 5 ig/mmn. Clearance periods were taken,
and end-proximal tubules were punctured during hydro-
penia and again during steady-state glucagon infusion.
Proximal tubule fluid to plasma (TF/P) inulin ratios were
used as an index for salt and water reabsorption at this
nephron site. Tubular transit time with lissamine green was
taken from the capillary flush until end-segments about a
star cluster had emptied. e) in eight dogs, clearance periods
were obtained sequentially under the following conditions:
1) hydropenia control; 2) acetylcholine bromide infusion
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into the left renal artery (60 to 80 jtg/min); 3) phase two
plus glucagon 5 jsg/min administered intravenously; 4) the
continuation of the acetylcholine and glucagon infusions
plus atropine sulfate 1 mg/kg body wt administered intra-
venously. This dose has been shown by Vander (7) and
by our own laboratory to completely block the renal effects
of acetylcholine within 15 to 20 mm without in itself affect-
ing renal function as measured by urine flow, sodium
excretion, GFR and PAH clearance. f) clearance studies
were performed in four dogs with chronic constriction
of the thoracic inferior vena cava during hydropenia and
again following the administration of glucagon intra-
venously at 5 j.tg/min. All animals had gross ascites. Urine
was collected from an indwelling bladder catheter during
these studies.
Analyses. Inulin in plasma and urine was analyzed by an
anthrone method [8] and in tubular fluid by the micro-
fluorometric technique of Vurek and Pegram [9] modified
to a 10 mm boiling time. Studies showed that the dosages of
glucagon that were employed did not cause sufficient
hyperglycemia to interfere with inulin analysis. There was
never any glycosuria during these studies as tested with
Combistix test paper. PAH was determined by an auto-
analyzer technique [10]. Sodium was measured on a flame
photometer with an internal lithium standard. Clearances
were calculated by standard formulas. Statistical signifi-
cance at the 5% probability level was calculated by the
Student "t" test.
Results
In most of the experiments, urine was collected separately
from ureteral catheters; in some, glucagon was administered
into the left renal artery. To verify that these manipula-
tions did not cause disparate changes of renal function,
clearance data were evaluated separately for each kidney
during the control phase of the experiments. Function was
equivalent for both kidneys: 0.46±sEM 0.07 vs. 0.42±
0.08 mI/mm for urine flow; 24.3± 2.71 vs. 21.4± 3.7 sEq/
mm for sodium excretion; 27.8± 1.15 vs. 26.2± 1.76 mI/mm
for GFR and 77.4±4.3 vs. 76±5.3Oml/min for CPAH.
Therefore, unless otherwise stated, the data presented are
for the left kidney only.
Clearance data. At a dose level of 5 JIg/mm of glucagon,
each kidney responded similarly to the infusion no matter
whether it was administered through a vein or through
the left renal artery. Hence, both types of experiments
are considered together. Of 26 experiments, 11 represented
direct intraarterial injection and the remainder were
peripheral i.v. infusions. Table 1 summarizes the effect of
glucagon infusion alone in 26 hydropenic dogs.
Within five minutes of starting the infusion a modest
diuretic response could already be seen. On the average,
urine flow doubled and sodium excretion increased by
65 7.1 jsEq/mmn/kidney. GFR increased by 30% while
PAH clearance increased by only 18%, thus leading to a
mean increase in filtration fraction of 4%. This latter
value just reached significance at the 5% level. Arterial
blood pressure generally remained constant or fell slightly.
Changes in the fractional excretion of sodium and water
were very small, but quite significant.
Fig. 1 summarizes the response of GFR to glucagon
infusion in 26 dogs. In all but two animals there was an
increment in GFR ranging from 1 to 24 ml/min/kidney.
In two dogs, GFR actually doubled. In the two dogs where
GFR fell, the decrement ranged from 1 to 3 mI/mm/kidney.
That this usual augmentation of GFR was not an artifact
of inulin analysis caused by glucagon-induced hyper-
glycemia was demonstrated in two dogs where inulin and
exogenous creatinine clearances were measured simultane-
ously. In these experiments, C1 and Cr agreed to within
5% in all phases of the experiment.
In the two animals where GFR fell following glucagon,
filtered sodium declined by 180 and 280 JtEq/min. In these
dogs, sodium excretion increased by 4 and 71 JIEq/min
respectively. In the remaining 24 dogs, the increment in
filtered sodium following glucagon ranged from 250 to
6440 .LEq/min while the increment in excreted sodium
ranged from 3 to 271 jsEq/min. In 14 of 26 dogs the in-
crement in excreted sodium exceeded 50 jsEq/min/kidney.
The relationship between increments in filtered load of
sodium and excreted sodium for the 24 dogs where glucagon
caused an increment in GFR is shown in Fig. 2. If, for
example, 10% of the increment in filtered sodium were
excreted, the points should fall along the 10% line of
identity. As shown, most points fall below this line in-
Table 1. The effects of glucagon on renal function
V
mi/mm
UV
iEq/mmn
C1
mi/mm
CPAH
mi/mm
FF Blood
pressure
mm Hg
FE H20
%
FE Na
%
Hydropenia 0.46±0.05 24.3±2.71 27.8±1.15 77.4±4.3 0.36±0.01 108.9±2.4 1.65±0.22 0.61±0.10
Glucagon 0.99±0.10 89.7±7.1 36.2±1.8 91.5±4.8 0.40±0.02 104 2.74±0.20 1.64±0.17
P 0.01 0.01 0.01 0.05 0.05 NS 0.05 0.01
Abbreviations: V= rate of urine flow, UNaV= urinary sodium excretion, C1, = inulin clearance, CPAH= PAH clearance, FF= filtration
fraction, FE= fractional excretion.
Data are for one kidney only. Values are means SE
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this percentage varied from 9.5 to 29%. The mean ratio
of LUNaV to filtered sodium load was 6.14±sEM 1.32%
for these 24 animals. These data therefore indicate that in
24 of 26 dogs, the increment in filtered load of sodium
following glucagon could easily account for the observed
increment in excreted sodium.
Aortic clamping. To further assess the relative contribu-
tion of increased GFR and possibly an altered tubular re-
absorptive capacity to the glucagon-induced natriuresis,
clearance measurements were made during steady-state
control, experimental and "clamp" periods as described in
Methods. In the "clamp" periods, an attempt was made
to return sodium excretion as closely as possible to pre-
glucagon levels. The results in nine dogs where clamping
was carried out following the infusion of glucagon are
tabulated in Table 2. Each datum represents the mean
of three or four steady-state clearance measurements. In
each case, glucagon caused an increment in both GFR,
filtered sodium and UNaY. Following the clamping
procedure, in eight of nine experiments GFR returned to,
or remained above, control levels despite the approxima-
tion of sodium excretion to pre-glucagon levels. In one
experiment (Dog #C4), GFR fell to 4 mI/mm (13.3%)
below control when UNaV was returned to baseline values,
thus suggesting depression of fractional sodium reabsorp-
tion. In five dogs, the clamping procedure was reversed
so that the clamp was released following the administra-
tion of glucagon. A representative experiment is shown in
Table 3. The i.v. infusion of glucagon caused a mean
L\UNaV of 24 pEq/min from the unclamped kidney and
it did not alter sodium excretion from the clamped side
significantly (AUNaV= 2 .tEqfmin). The tendency for
UNaV to rise on the clamped side during the third phase
of the representative experiment probably represents
limitations in measurements and was not observed in the
four other experiments. In these four other animals, the
Dog GFR1a
mi/mm
GFR2b
mi/mm
GFR3C
mi/mm
UNaV1
pEq/mmn
UNaV2
pEq/mmn
UNaV3
pEqimin
1 25 33 26 8 69 14
2 20 41 34 5 58 21
3 24 32 29 50 167 42
4 30 34 26 7 24 5
5 26 30 29 55 168 59
6 31 42 33 11 137 8
7 31 37 38 19 125 14
8 24 26 24 29 118 33
9 36 41 35 45 237 52
Mean 27.4 35.1 30.4 25.4 122.6 27.6
pd 0.05 NS 0.01 NS
a control period; b during glucagon infusion; C during clamping.
P values compare each period to control phase.
dicating the small percentage of filtered sodium which was
excreted. In 17 of 24 dogs, the percentage of increased
filtered sodium required to account for the increment in
UNa V was less than 5 %. In the remaining seven dogs
.
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Fig. 1. The effect of glucagon on GFR. Points above the line
represent the increments from control, points below the line
represent a fall in GFR. Each point is the mean of at least three
clearance periods in each phase of the experiment. The arrows
indicate two dogs where GFR doubled.
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Fig. 2. The fraction of the increment in filtered sodium following
glucagon appearing in the urine. Points falling along the upper
line would indicate that 10% of the filtered increment of sodium
was being excreted. Each point is the mean of at least three
clearance periods. The arrow points to the highest value obtained.
Table 2. The effects on GFR of returning sodium excretion to
preglucagon levels by aortic clamping
S
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Time
mm
V UNaV GFR FL Na
mi/mm pEq/min mi/mm yEq/mmn
E C E C E C F C
—127
0— 8
8— 14
14— 22
23
Start inulin prime and constant infusion at 0.5 mi/mm
0.48 0.51 18 10 24 23 3550 3400
0.60 0.62 22 12 23 22 3400 3260
0.45 0.41 17 8 18 18 2670 2670
Tighten Blalock clamp above left renal artery
45— 60
60— 76
76— 90
91
0.34 0.64 10 21 19 23 2800 3400
0.19 0.64 6 24 16 24 2350 3520
0.28 o.so 9 18 15 24 2200 3520
Start glucagon i.v. at 5 pg/mm. Keep clamp tightened
106—116
116—126
126—136
137
0.19 1.2 5 37 19 31 2800 4500
0.28 1.2 10 48 15 27 2200 4010
0.28 1.4 17 49 16 27 2350 4010
Release clamp. Maintain glucagon infusion
153—161
161—171
171—181
1.0 1.2 36 40 28 27 4140 4010
1.0 0.66 34 37 29 27 4270 4010
0.80 0.86 28 36 26 26 3880 3880
183
210—225
Stop glucagon infusion
0.23 0.27 6 6 17 18 2500 2650
mean AUNaV3 from the clamped kidney following systemic
glucagon infusion was: 0.0, 0.0, +1 and —3 jsEq/min,
respectively, while the AUNaV from the contralateral side
was 28, 34, 40, and 42 Eq/min, respectively. In each dog,
these changes in sodium excretion were accompanied by
mean increments in GFR on the unclamped side of 3, 4,
4, and 5 ml/min, and a corresponding lack of change on the
clamped side (0, 0, 0 and —1 mI/mm). When the clamp was
released, both sodium excretion and GFR rose on the
experimental side to become equal in magnitude to that
observed in the control kidney. Both types of clamping
procedures therefore suggest that the natriuresis following
glucagon is dependent upon increments in the filtered load
of sodium.
Micropuncture data. Renal vasodilators such as acetyl-
choline, prostaglandins and dopamine are known to cause
a natriuresis in dogs by virtue of their ability to depress
fractional reabsorption of salt and water in the proximal
tubule [11 12]. Since glucagon is a known dilator of the
renal vasculature [13], function in the proximal tubule
was more closely examined by recollection micropuncture
in five dogs during hydropenia and again following
glucagon administration. Fig. 3 summarizes the TF/P inulin
data in 24 nephrons. The mean TF/P inulin ratio during the
control phase was 1.79 and this fell to 1.75 following gluca-
gon, but the change was not significant. GFR in the experi-
Comparison is here being made between the second phase of
the experiment (clamped left kidney) and the third phase
(clamped left kidney plus i.v. glucagon).
Fig. 3. The effect of glucagon on fractional reabsorption in the
proximal tubule. Each point represents a paired recollection.
mental kidney increased by 24% (29.3 to 36.1 mI/mm;
Pc 0.05) while PAH clearance increased by only 11 %
from 86 to 95.5 mI/mm (NS). This led to an increase in
filtration fraction from 0.33 to 0.38 (P<0.05). Mean
sodium excretion increased from 20.3 to 99.6 tEq/min/
kidney.
While superficial single nephron GFR was not measured
in these studies, it seems quite likely that this variable
increased following glucagon, possibly by the same order
of magnitude as did whole kidney GFR. The evidence for
such an increment is indirect. Fluid entered the puncture
pipette more easily following the glucagon infusion, and
proximal tubule transit time (lissamine green) decreased
by 17.7% from 19.2±0.3 to 15.8±0.4sec (P<0.05). Since
fractional reabsorption remained constant following gluca-
gon, this decrease in transit time is interpreted to mean
that filtration into the superficial nephrons must have
increased. If superficial nephron GFR did indeed increase,
and if fractional reabsorption in the proximal tubule did
not, absolute sodium reabsorption must have therefore
been augmented to maintain glomerulotubular balance as
GFR was changing in an incremental direction. These
results would suggest that glucagon does not disrupt
glomerulotubular balance as GFR is changing and that it
probably does not exert an important net inhibitory effect
on the proximal tubule. However, because of the very
small increment in sodium excretion that is induced by
glucagon, the change in fractional tubular reabsorption
that would be necessary to produce such an increment
would be quite small. If the proximal tubule was the site
of a direct tubular effect of glucagon, it is conceivable that
a minor depression of tubular sodium transport would be
beyond the limits of detection via micropuncture and usual
analytical techniques. A very small tubular effect therefore,
cannot be definitely excluded.
Acetyicholine infusion. To ascertain whether or not
glucagon possesses an indirect tubular effect mediated
by its effect on renal hemodynamics, we tested the effect
Table 3. The effect of unilateral renal arterial clamping on the
response to glucagon
S.2.2a
C)
.9 2.0
aUU
1.8aa
CO
cCU
0
1.4
aa
:1.2
H
S •
S
.
S
1.2 1.4 1.6 1.8 2.0 2.2
TF/P Inulin-Control
Abbreviations: FL= filtered load; F =experimental kidney;
C= control kidney.
Glucagon-induced natriuresis in dogs 81
Fig. 4. The effect of prior renal vasodilation on the response to
glucagon. Closed circles represent control kidney, open circles
the vasodilated kidney. Each point is the group mean 1 5EM
Ach= acetylcholine; ATR =atropine. Note the similar incre-
ments of UNaV for each kidney despite a greatly disparate CPAH
response to the glucagon.
of i.v. glucagon after having first dilated the left kidney
with acetylcholine (60 to 80 .tg/min) delivered into the
renal artery. The data from eight such experiments are
summarized in Fig. 4. Acetylcholine increased CPAH of the
experimental kidney by 48.5% (P<0.01) and UNaV by
60 j.tEq/min (105%). GFR remained unchanged. The super-
imposed systemic administration of glucagon was associated
with an average rise of GFR of 19.8% on the experimental
side and 27.7% on the contralateral side. Despite these
equivalent increments in GFR for each kidney, CPAH did
not rise further on the acetylcholine side, but it increased
by approximately 90% on the control side. Why the con-
trol kidneys responded so dramatically to glucagon in this
series of experiments is not readily apparent. Despite these
markedly disparate responses in CPAH between the two
kidneys, the infusion of glucagon was accompanied by
average incremental rises of UNa V on the two sides that
were virtually equivalent (60±24 j.iEq/min for the acetyl-
choline-infused kidney and 81± 26 jtEq/min for the control
side). Both of these increments in sodium excretion were
significant at the 5% level. The data appear to indicate that
glucagon-induced natriuresis is unrelated to the ability
of glucagon to effect vasodilatation, but rather to its ability
to increase the filtered load of sodium.
The administration of atropine did not abolish the gluca-
gon induced natriuresis.
Chronic caval dogs. To determine whether glucagon
would have a natriuretic effect in animals with active
sodium retention, this polypeptide was administered to
four dogs with chronic partial constriction of the inferior
vena cava. All dogs had gross ascites, caval venous pressures
of at least 16 cm H20 and urinary sodium concentration
values during hydropenia ranging from 2 to 16 mEq/liter.
Following the infusion of glucagon at 5 1g/min, there was
Table 4. The effects of glucagon on chronic caval dogs a
Dog
GFR
mi/mm
Control Glucagon
GFR
%
Sodium excretion
jEq/min
Control Glu-
cagon
1 41 59 +43 5 30
2 83 119 +43.5 5 60
3 95 128 +34.7 4 80
4 46 86 +87 10 322
a All values are for two kidneys.
a prompt increase in water and sodium excretion. In every
instance there were marked increments in the filtered load
of sodium. The data are summarized in Table 4.
Discussion
The data reported in this paper demonstrate clearly that
in anesthetized dogs pretreated with large doses of mineralo-
corticoid, the intravenous infusion of glucagon causes a
modest but significant natriuresis. The increment in sodium
excretion must therefore be due to an increment in the
filtered load of sodium, to a depression of tubular reabsorp-
tive capacity f or sodium (non-aldosterone mediated),
or to a combination of these factors. The evidence presented
in these studies is consistent with the thesis that the observed
glucagon-induced natriuresis is due largely to increments
in the filtered sodium load, and that if this polypeptide
has any tubular effects, they are most likely small and
quantitatively unimportant.
In 24 of 26 animals, an increase of GFR was observed
following the glucagon infusion concomitant with an
increased urinary sodium excretion. While such a parallel
relationship does not prove cause and effect, it never-
theless satisfies a necessary prerequisite f or ascribing alter-
ations in urinary sodium excretion to alterations in filtered
load. As indicated in Fig. 2, very small amounts of the in-
crement in filtered sodium following glucagon infusion
would have to escape tubular reabsorption to account f or
the measured increments in urinary excretion. This observa-
tion alone makes it unnecessary to postulate an effect
of glucagon on tubular transport processes.
The results of the aortic clamping experiments also
suggest that the increment in GFR can completely account
for the glucagon-induced natriuresis. In the first set of
studies, soditim excretion was returned to pre-glucagon
levels with the aid of the clamp. If glucagon had been
responsible f or significant inhibition of tubular reabsorp-
tion of sodium, then "clamp" GFR should have been
found below control levels. This was true for only one of nine
dogs. These data are therefore interpreted to mean that the
glucagon-induced natriuresis was caused by the augmented
GFR. Such an interpretation however, is open to challenge
upon methodological grounds. The use of the clamp
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to reduce filtered sodium load may alter tubular transport
by altering perfusion pressure, and indeed recent micro-
puncture studies in dogs confirm that aortic clamping may
cause incomplete glomerulotubular balance in the proximal
tubule resulting in increased fractional reabsorption [14].
If glucagon therefore produced inhibition of sodium
transport at some point along the nephron, this effect
might be obliterated by an opposing effect of clamping
which might more or less restore fractional reabsorption
to its previous level. That clamp-induced alterations in
tubular transport would exactly balance glucagon-induced
alterations seems most unlikely in view of the variation
in magnitude of sodium excretion from dog to dog (24 to
237 jjEq/min).
In addition to the argument noted above, if the natriuretic
effects of glucagon were due mainly to a tubular effect,
this would imply that the large increment in GFR following
glucagon, and the decrement following the clamping
procedure would not importantly influence urinary sodium
excretion. Not only is this at variance with other data
[15, 16], but the assumption that large changes in GFR
could not influence urinary sodium excretion would
contravene current physiological concepts [17]. Although
the possibility of a small, direct tubular effect for glucagon
is not rigorously ruled out by the first set of clamping
studies, it is made much less likely by the second series
of studies in which the clamp was tightened prior to the
infusion of glucagon. In these experiments, no matter
what the effects of the clamp might be, presumably a
new steady-state had been reached prior to the infusion
of glucagon. With the introduction of glucagon into the
circulation, some increment in UNaY should occur if
glucagon is indeed capable of exerting a direct tubular effect.
In fact, none was observed until the clamp holding perfu-
sion pressure constant was released allowing GFR to rise.
Thus, when GFR is prevented from rising, a natriuretic
effect of glucagon is not observed. Of course, removal
of the clamp also allows renal perfusion pressure to rise.
If therefore, glucagon has a tubular action mediated by
increments in intrarenal perfusion pressure, such an effect
would be obliterated while the clamp was tightened. The
present data do not exclude this possibility. However, the
observation that glucagon has a predominant preglomerular
rather than postglomerular action (thus minimizing trans-
mission of perfusion pressure to the peritubular capillaries),
and the results of the acetylcholine experiments (Fig. 4),
minimize the likelihood that glucagon acts in this way.
These observations, together with the data from the first
set of clamping studies, make a tubular effect for glucagon
unlikely. Certainly if one exists, the amount of sodium
being contributed to the final urine must be quite small
when compared to that escaping tubular reabsorption via
an increment in filtered load.
The data obtained in the micropuncture experiments
also support the view that the glucagon-induced natriuresis
is due to the increment in filtered sodium. Since glucagon
is a renal vasodilator [13] one would have presupposed an
effect at the level of the proximal tubule were this poly-
peptide capable of depressing tubular sodium reabsorption.
No such effect on fractional sodium reabsorption was
observed. Although distal tubular micropuncture data are
not available, the clamping studies tend to rule out tubular
inhibition at any nephron site as a cause for the natriuresis.
In any event, the large increment in filtered sodium makes
it unnecessary to postulate a direct tubular action.
The constancy of TF/P inulin in the proximal tubule
following glucagon infusion, despite large changes in GFR
implies that glomerulotubular balance is complete in
hydropenic dogs when GFR is changed in an incremental
direction. This same conclusion has previously been arrived
at by Lindheimer, Lalone and Levinsky [16] on the basis
of clearance studies. Since whole kidney GFR increased
by 24% in the micropuncture studies, and transit time
decreased by 17.7% in the face of constant TF/P inulin
ratios, it seems likely that single nephron GFR of the super-
ficial tubules available for puncture increased roughly
by the same order of magnitude as did whole kidney GFR.
Such a sequence of events would lead to increased absolute
sodium reabsorption in the proximal tubule4. Since PAH
clearance in these dogs increased by 11 %, the resultant
increase in filtration fraction (0.33 to 0.38) was significant.
The resultant increase in postglomerular capillary protein
concentration and colloid osmotic pressure could have
been, at least in part, the mechanism whereby absolute
sodium reabsorption increased in response to the increased
filtered load5. The importance of peritubular capillary
protein concentration in mediating changes in absolute
reabsorption by the proximal tubule has recently been
demonstrated in rats by micropuncture techniques [18].
The observation that infusions of glucagon elevate GFR
is in agreement with previous reports by some authors [6],
but it is at variance with the results of other studies [2, 20].
However, in the published studies in which it is claimed
that glucagon either does not elevate GFR or an incre-
ment in filtered sodium is not the cause of the natriuresis,
the reported data do not tend to support the authors'
claims. Thus, Staub et al [2] originally reported that gluca-
gon did not elevate GFR in dogs. However these authors
were using the relatively inaccurate method of endogenous
creatinine clearance to monitor changes in GFR and,
This supposition is based on the assumption that glucagon
does not cause redistribution of renal plasma flow to the inner
cortex or medulla. Given the large order of magnitude of
change in whole kidney GFR, and given that superficial tubules
form the bulk of cortical nephrons, it would seem highly
unlikely that such a change in whole kidney GFR could be
maintained in the face of major redistribution away from the
outer renal cortex.
This thesis assumes that filtration fraction of superficial
nephrons in hydropenic dogs is equivalent to whole kidney
filtration fraction. Although no micropunèture data are
available in the dog, recent evidence in the hydropenic rat
suggest that this is indeed the case [19].
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moreover, they were testing single injections of the hormone
rather than constant infusions. They may therefore, have
been measuring GFR under non-steady state conditions.
The authors present no data for critical evaluation but
merely state that the variation of GFR for most dogs was
within 10%.
The report of Stowe and Hook [20] also concludes that
glucagon does not elevate GFR in dogs. However, when
glucagon was infused i.v. at 0.5 gg/Kg/min (a comparable
dose to that used in our experiments), the authors state
that considerable variation occurred between animals, and
indeed in their Fig. 2, the AGFR for 22 kidneys (11 dogs)
varied from —4 to + 25 mI/mm. In 16 of 22 kidneys, GFR
increased in response to the glucagon infusion; and in 11
of these the AGFR was in excess of 5 mI/mi In their
Table 2, when glucagon was infused directly into the left
renal artery at 1 to 10 jig/mm, mean GFR in five dogs
increased from 28 to 35 mI/mm (+ 25%). Although this
change was apparently not significant, its magnitude is
beyond the usual limits of error for measuring GFR
(±10%) and implies that at least in some dogs, glucagon
must have caused GFR to rise significantly.
Pullman, Lavender and Aho [6] also concluded that the
natriuretic effects of glucagon in the dog were due to
direct tubular action. These workers infused glucagon into
one renal artery, and while they observed bilateral in-
crements in GFR they also observed a differentially greater
urinary excretion of sodium on the infused side than on the
control side. However the differential GFR between
experimental and control kidneys following glucagon was
2.8 ml/min while the plasma sodium was 140 mFq/liter.
Thus, the mean differential increment in filtered load was
394 jiEq/min. This could easily explain the mean differ-
ential increment in urinary sodium excretion of 99 jiEq/min.
Indeed, in only four of 13 dogs could the measured differ-
ential increment in filtered load of sodium between the
two kidneys fail to account for the increment in differential
urinary excretion of sodium. It is therefore our opinion
that none of the prior studies in dogs, using comparable
doses of glucagon, have adequately ruled out the possibility
that increments in filtered sodium are the cause of the
observed natriuresis. Certainly the data presented by the
authors are far from conclusive.
From the data reported in these and other experiments
[6], glucagon appears to be a mild renal vasodilator with
a predominant preglomerular action so that GFR rises
far more than PAH clearance. Three lines of evidence
suggest that glucagon has a direct renal effect rather than
a secondary effect mediated through augmentation of
cardiac output. First, filtration fraction in the present
experiments tended to rise. This would probably not occur
if the kidney were able to autoregulate and if it were
simply receiving a larger share of the cardiac output.
Secondly, unilateral infusions of glucagon into one renal
artery may produce only unilateral increments in GFR
and UNaV at appropriate dose levels (unpublished observa-
tions). Lastly, Barac [21] has demonstrated in a three-dog
system that glucagon may be natriuretic even when the
heart of a donor dog receiving an injection of glucagon
is not included in the perfusing system of the kidneys
of a second animal.
The data in this study demonstrate that when GFR is
elevated without concomitant volume expansion, some
6% of the increment of filtered sodium will appear in the
final voided urine. These data are somewhat similar to
those previously reported by Lindheimer et al [16]. These
authors increased GFR in dogs by four different techniques
which did not involve volume expansion. The increment
in GFR varied from 27 to 34% and the mean increment in
UNaV varied from 17 to 53 jiEq/min (two kidneys). In
their experiments, about 1.5% of the increment in filtered
sodium appeared in the final urine. Although this value
is somewhat less than that reported in the present study,
the conclusions derived from both studies are similar, i.e.,
when the filtered sodium load is elevated in non-expanded
dogs, glomerulotubular balance is fairly complete so that
only minimal amounts of extra sodium appear in the urine.
The experiments with acetylcholine indicate that prior
vasodilatation of one kidney does not abolish the usual
response to glucagon. On the experimental side, the sub-
sequent infusion of glucagon increased cortical plasma
flow slightly by 9.6% (P>0.05), while plasma flow in-
creased on the control side by some 90% (P<0.0l).
Despite the large and very different effects on each kidney,
glucagon produced a similar increment in sodium ex-
cretion (60 and 80 jiEq/min), further demonstrating the
lack of influence of increased cortical plasma flow. The
increments in GFR were equivalent on each side (19.8%
and 27.7%) and were more than sufficient to account for the
extra natriuretic effect. The increment in excreted sodium
from the vasodilated kidney represented 7.5% of the extra
filtered load and was equivalent to the value from the control
kidney (7.14%). If acetyicholine decreases fractional re-
absorption in the proximal tubule [11] and possibly in
the loop of Henle [22], one would have anticipated a far
greater natriuresis from the dilated kidney following
glucagon infusion. We have no ready explanation to account
for the small magnitude of post-glucagon natriuresis from
the vasodilated kidney.
Because Vander [7] has demonstrated that increasing
acetylcholine infusion into one renal artery beyond
50 jig/mm has only further minimal effects on renal plasma
flow, at 80 jig/mm we presumably had effected maximal
or near-maximal vasodilatation which could occur with
this drug. The further effect of glucagon on the afferent
arteriole, and its insensitivity to atropine would suggest
that this polypeptide acts at "receptor sites" different from
acetylcholine.
The failure of prior renal vasodilation to prevent the
natriuretic effect of glucagon is in conflict with the recent
conclusions of Stowe and Hook [20]. These investigators
observed that increasing renal blood flow in dogs by some
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88% via the infusion of hypertonic mannitol obviated the
hemodynamic and natriuretic effects of glucagon. They
concluded therefore, that in order for glucagon to increase
sodium excretion, it must first cause renal vasodilatation.
However, in their experiments OFR in the experimental
phase was on the average some 32 % lower than control
values ([20], Table 2). Because of this marked fall in OFR
the absence of a natriuretic effect is not surprising and the
authors' results are open to alternative explanation.
Finally, when glucagon was infused into chronic caval
dogs actively retaining sodium, marked increments in
GFR were observed. The observation that glucagon is
pharmacologically active at the preglomerular level in
edematous dogs suggests that this hormone may prove
useful as a diuretic adjunct in the various edematous states
where the delivery of sodium to the loop of Henle may be
a limiting factor in diuretic effectiveness.
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